Detecting Sepsis in Patients With Severe Subarachnoideal Hemorrhage

Completed

• Conditions: Subarachnoid Hemorrhage; Sepsis; Sepsis, Severe; Subarachnoid Hemorrhage, Aneurysmal; Sepsis Syndrome; Sepsis Bacterial

• Registration Number: NCT05246969
• Lead Sponsor: Goethe University

Brief Summary

The study aims to evaluate the suitability of the SOFA score implemented by the Sepsis 3 guideline to detect sepsis in patients suffering from subrarachnoid hemorrhage.

Detailed Description

Not available

Study Timeline

• Study Start: 2017-06-01
• Primary Completion: 2018-06-01
• Study Completion: 2022-02-01
• Study First Submitted: 2022-02-09
• Study First Submitted QC: 2022-02-17
• Study First Posted: 2022-02-18
• Status Verified: 2022-03
• Last Update Submitted: 2022-03-14
• Last Update Posted: 2022-03-29

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 58

Inclusion Criteria

Critically ill patients suffering from moderate to severe subarachnoid hemorrhage (WFNS >2).

Exclusion Criteria

children under the age of 18 years Patients with minor subarachnoid hemorrhage < WFNS stage 2.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Sepsis SOFA positive	up to 2 months	Sepsis correctly detected by SOFA score (Sepsis-related organ failure assessment score, 0-24 points)
Sepsis SOFA negative	up to 2 months	Sepsis not detected by SOFA score (Sepsis-related organ failure assessment score, 0-24 points)

Trial Locations

Locations (1)

University Hospital Frankfurt; 🇩🇪 Frankfurt Niederrad, Hessen, Germany